# Why doesn't shoulder cartilage heal quickly?

*Shoulder regeneration Gilbert | Why cartilage heals slowly*

> Shoulder regeneration Gilbert explained plainly: why cartilage heals slowly, why a scan may not match soreness, and how your shoulder can still improve.

This page explains why worn cartilage heals slowly. Cartilage lets the joint surfaces glide. It doesn't have its own blood supply.

That limits repair in a worn area. Still, your shoulder may move and feel better. Strong muscles can share more of the work.

## What does cartilage do in my shoulder?

Cartilage makes a smooth cover over the joint. It helps your arm move with less rubbing. Worn cartilage usually heals very slowly.

Arthritis can thin that smooth cover. The joint may then ache or feel stiff. You'll sometimes notice grinding during movement.

Cartilage itself has no nerves. Nearby bone and soft tissue can hurt. Pain and the amount of wear don't always match.

Your shoulder can work better around worn cartilage. Strong muscles can guide your arm more smoothly. They won't replace cartilage, but daily use may improve.

## Why can my scan look worse than I feel?

Scans often show wear in older shoulders. Some worn tendons don't cause symptoms. A scan can't measure your daily limits.

Clinic staff also check motion and strength. You'll explain how the soreness started. The exam helps find its likely cause.

The scan still has value. It can confirm some kinds of damage. It can't choose your care by itself.

## Can my shoulder improve without new cartilage?

Yes, because muscles help control the joint. Better control can make reaching feel easier. You'll sometimes sleep better when soreness eases.

QC Kinetix provides regenerative shoulder treatment choices, meaning clinic staff examine you and use a prepared part of your blood in care meant to support repair. It'll aim for less soreness. It isn't proof of new joint surface.

Track what you can do each week. Note your sleep, reach, and easy lifting. You'll see whether daily use has changed.

## Sources

1. A concise review of mesenchymal stem cells for functional cartilage tissue engineering sets out the underlying problem: articular cartilage is avascular and has very limited intrinsic repair capacity, which is precisely why engineered and cell-based approaches are being pursued - and why building tissue that matches native articular cartilage in composition and mechanical function remains an unsolved engineering problem rather than a delivered clinical product.
   Tan AR, et al. — [Concise Review: Mesenchymal Stem Cells for Functional Cartilage Tissue Engineering: Taking Cues from Chondrocyte-Based Constructs.](https://pubmed.ncbi.nlm.nih.gov/28177194/). *Stem cells translational medicine*, 2017. DOI: 10.1002/sctm.16-0271.
2. A systematic review of the discordance between clinical and radiographic knee osteoarthritis: many people with severe-looking x-rays have little pain, and many with disabling pain have modest radiographic change. This is the reason a post-treatment scan is a poor proxy for how someone feels, in either direction.
   Bedson J, et al. — [The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature.](https://pubmed.ncbi.nlm.nih.gov/18764949/). *BMC musculoskeletal disorders*, 2008. DOI: 10.1186/1471-2474-9-116.
3. FORWARD, the longest disease-modifying osteoarthritis drug trial reported to date, gave intra-articular sprifermin (a recombinant FGF-18) or placebo to knee OA patients and followed 378 of them for 5 years. Sprifermin produced a significant, sustained dose-response INCREASE in total femorotibial cartilage thickness versus placebo - and WOMAC pain improved about 50% from baseline in ALL groups, including placebo. It is the cleanest demonstration in the literature that adding measurable cartilage and relieving pain are two different results, and that one does not deliver the other.
   Eckstein F, et al. — [Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.](https://pubmed.ncbi.nlm.nih.gov/33962962/). *Annals of the rheumatic diseases*, 2021. DOI: 10.1136/annrheumdis-2020-219181.
4. Eighty patients with a single symptomatic chronic femoral condyle cartilage defect were randomized to autologous chondrocyte implantation or microfracture and followed 14-15 years. No significant difference in clinical scores emerged at long-term follow-up; there were 17 failures in the ACI group versus 13 in the microfracture group and more total knee replacements after ACI (6 versus 3). Fifty-seven percent of surviving ACI patients and 48% of surviving microfracture patients had radiographic early osteoarthritis (KL >=2).
   Knutsen G, et al. — [A Randomized Multicenter Trial Comparing Autologous Chondrocyte Implantation with Microfracture: Long-Term Follow-up at 14 to 15 Years.](https://pubmed.ncbi.nlm.nih.gov/27535435/). *The Journal of bone and joint surgery. American volume*, 2016. DOI: 10.2106/JBJS.15.01208.
5. The SUMMIT randomized trial treated 144 patients (mean age 33.8, mean lesion 4.8 cm2) with at least one symptomatic focal cartilage defect (Outerbridge III/IV, >=3 cm2) of the femoral condyle or trochlea. Matrix-applied characterized autologous cultured chondrocytes (MACI) improved KOOS pain (37.0 to 82.5) and function significantly more than microfracture (pain 35.5 to 70.9) at 2 years, with histological and MRI assessment of the repair tissue. This is what a positive cartilage-repair trial looks like - in young patients with a discrete hole, not a worn joint.
   Saris D, et al. — [Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Two-Year Follow-up of a Prospective Randomized Trial.](https://pubmed.ncbi.nlm.nih.gov/24714783/). *The American journal of sports medicine*, 2014. DOI: 10.1177/0363546514528093.
6. In a nationally representative Finnish population sample of 602 adults aged 41-76 who had bilateral 3-Tesla shoulder MRI regardless of symptoms, rotator cuff abnormalities were found in 98.7% of participants (25% tendinopathy, 62% partial-thickness tear, 11% full-thickness tear). Abnormalities were present in 96% of ASYMPTOMATIC shoulders. Only full-thickness tears were more common in symptomatic shoulders, and that difference all but disappeared after adjustment (absolute difference 0.8%, 95% CI -3.4% to 6.0%).
   Ibounig T, et al. — [Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging.](https://pubmed.ncbi.nlm.nih.gov/41697693/). *JAMA Intern Med*, 2026. DOI: 10.1001/jamainternmed.2025.7903.

## What is your next shoulder step?

At the Chandler office, QC Kinetix offers regenerative care, meaning treatments prepared from part of your blood and intended to support repair. Clinic staff can examine your shoulder and discuss choices. They may find that different care fits better.

Bring prior scans and notes listing your medicines. Note which movements make the soreness worse. You'll leave knowing which choices fit the exam.

Book a free consultation: <https://shoulder.qckaz.com/?src=shoulderregenerationgilbert.com>

---

Plain help for soreness and easier movement.

Shoulder regeneration Gilbert information on sore shoulders, simple care at home, signs needing attention, non-surgical choices, and the nearby Chandler clinic.

Plain help for shoulder soreness, warning signs, and care near Gilbert.

This site, including its recommendation of the Chandler location, is operated by the owners of the QC Kinetix Phoenix-area clinics; those owners benefit when a reader books a consultation.

Copyright 2026 Gilbert Shoulder Field Notes. General shoulder education only; urgent symptoms need prompt medical care, and individual decisions require an examination.
